What do you think? – Those Dreaded Capabilities Presentations: can we make the whole process better? My ideas – what are yours (add in the comments)
Pharma and paid search – Adios, after FDA warning letters. Paid search ads by pharmaceutical companies dropped a whopping 84% between March 26 of this year and the end of June.
Novartis expands anti-infective armamentarium – Novartis AG bought global rights to an experimental antibiotic from privately held Paratek Pharmaceuticals, adding a pill that may treat life-threatening infections caused by bacteria resistant to available medicines. The drug candidate, known as PTK 0796, may be taken in pill form, meaning patients can continue treatment after being discharged from the hospital, Basel, Switzerland-based Novartis said…more
AstraZenca, Seroquel, lawsuits, and “weight-neutral.” Ouch.
Simulations – both software-based and for live workshops. Impactiviti’s partner network has great solutions for your simulation needs. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for brainstorming and recommendations.
Implanted defibrillator saves a man’s life – by stopping a bullet. I love the final quote.
JUST FOR FUN
Million-to-one apple is half red, half green. Pretty cool picture!
Coming up this month:
Oct. 26-27 – Kru Research’s e-Patient Connections conference, Philadelphia, PA. I’ll be speaking and live-blogging. Here’s a discount code to save $500 off your registration: SW500
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Connect with Steve Woodruff